Evidence map›Paper›PMID 18410367›Full record

ArticleEpilepsia2008

Seizure remission and relapse in adults with intractable epilepsy: a cohort study.

Hyunmi Choi, Gary Heiman, Dionysis Pandis, Julio Cantero, Stanley R Resor, Frank G Gilliam, W Allen Hauser

Abstract read
In one paragraph

Article in Epilepsia, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Recent advances in epilepsy.Journal of neurology · 2017
    Review
  10. Seizing Control: From Current Treatments to Optogenetic Interventions in Epilepsy.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2017
    Article
  11. Article
  12. New Techniques and Progress in Epilepsy Surgery.Current neurology and neuroscience reports · 2016
    Review
  13. Managing drug-resistant epilepsy: challenges and solutions.Neuropsychiatric disease and treatment · 2016
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Hyunmi ChoiDepartment of Neurology, The Neurological Institute, Columbia University, New York, New York 10032, USA.
Gary Heiman
Dionysis Pandis
Julio Cantero
Stanley R Resor
Frank G Gilliam
W Allen Hauser

Funding

MENTORED CLINICAL RESEARCH SCHOLAR PROGRAMK12RR017648 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2002 to 2006
$2.8M
Shared Genetic Risk for Epilepsy and DepressionK23NS054981 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI HEIMAN, GARY A. · 2007 to 2011
$758k
Clinical Research in Epilepsy and Associated DisordersK24NS047551 · NINDS · WASHINGTON UNIVERSITY · PI GILLIAM, FRANK G · 2004 to 2007
$563k
NCRR NIH HHS K12 RR017648NINDS NIH HHS K23 NS054981NINDS NIH HHS K24 NS047551
6 · The paper itself

Abstract

purposeTo investigate the cumulative probabilities of >or=12 month seizure remission and seizure relapse following remission, and to test the associations of clinical characteristics with these two study end points in a prevalence cohort of intractable adult epilepsy patients during medical management.

methodsA retrospective cohort study of intractable epilepsy patients seen in 2001 at a single center was conducted. Kaplan-Meier analysis was used to estimate the cumulative probabilities of seizure remission and subsequent seizure relapse. Cox proportional hazards models were used to estimate the association (1) between clinical factors and >or=12 month seizure remission and (2) between clinical factors and seizure relapse following remission.

resultsOne hundred eighty-seven subjects met the eligibility criteria for intractable epilepsy. The estimate of probability of remission was about 4% per year. Seizure remission was temporary for some individuals, as 5 out of 20 subjects with remission ultimately relapsed. No clinical factors predicted the likelihood of achieving >or=12 month seizure remission or subsequent seizure relapse. DISCUSSION: Some people with intractable epilepsy achieve >or=12 month seizure remission during medical treatment. Remission, however, is only temporary for some individuals. We were unable to identify clear predictors for remission.

Indexed as

AdultAge of OnsetCognition DisordersCohort StudiesEpilepsy, GeneralizedFemaleHumansMaleNeuropsychological TestsPrevalenceRecurrenceRemission, SpontaneousSeizures

Identifiers

PMID18410367
PMCPMC3684178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.